Increasing tinea capitis prevalence in Stockholm reflects immigration

Medical Mycology

Volumn 42, Issue 6, 2004, Pages 505-509

  Hällgren, Jenny ^a   Petrini, Björn ^a   Wahlgren, Carl Fredrik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dermatophyte infection; Mycosis; Scalp; Trichophyton violaceum

Indexed keywords

ANTIBIOTIC AGENT; GLUCOCORTICOID; GRISEOFULVIN; KETOCONAZOLE; TERBINAFINE;

ADOLESCENT; ALOPECIA; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOPHYTE; DIARRHEA; DISEASE TRANSMISSION; ETHNOLOGY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMIGRATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NONHUMAN; POPULATION DISTRIBUTION; PREVALENCE; PRURITUS; RETROSPECTIVE STUDY; RISK ASSESSMENT; STOMACH PAIN; SWEDEN; TINEA CAPITIS; TRICHOPHYTON VIOLACEUM; VOMITING;

ADOLESCENT; ALOPECIA; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; EMIGRATION AND IMMIGRATION; FAMILY HEALTH; FEMALE; GRISEOFULVIN; HUMANS; INFANT; INFANT, NEWBORN; MALE; NAPHTHALENES; PRURITUS; RETROSPECTIVE STUDIES; SWEDEN; TINEA CAPITIS; TRICHOPHYTON;

TINEA; TRICHOPHYTON; TRICHOPHYTON VIOLACEUM;

EID: 12144250590     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/13693780310001644725     Document Type: Article

References (25)

1. Wahlgren CF, Kaaman T, Wikstrom U. Exotic tinea. Increased occurrence among children in the district of Stockholm. Läkartidningen 1993; 90: 1761-1763.
2. Gupta AK, Summerbell RC. Tinea capitis. Med Mycol 2000; 38: 255-287.
3. Hay RJ, Robles W, Midgley G. Tinea capitis in Europe: new perspective on an old problem. JEADV 2001; 15: 229-233.
4. Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol 2000; 42: 1-20.
5. De Hoog GS, Guarro J, Gené J, Figueras MJ. Atlas of Clinical Fungi, 2nd edn. Utrecht, The Netherlands: Centraalbureau voor Schimmelkultures, 2000.
6. Campbell CK, Johnson EM, Philpot CM, Warnock DW. The dermatophytes. In: Campbell CK, Johnson EM, Philpot CM, Warnock DW (eds). Identification of Pathogenic Fungi. London: Public Health Laboratory Service, 1996; 26-71.
7. Lamb SR, Rademaker M. Tinea due to Trichophyton violaceum and Trichophyton soudanense in Hamilton, New Zealand. Australas J Dermatol 2001; 42: 260-263.
8. Chen BK, Friedlander S. Tinea capitis update: a continuing conflict with an old adversary. Curr Opin Pediatr 2001; 13: 331-335.
9. Lobato MN, Vugia J, Frieden IJ. Tinea capitis in California children: a population-based study of a growing epidemic. Pediatrics 1997; 99: 551-554.
10. Figueroa JI, Hawranek T, Abraha A, Hay RJ. Tinea capitis in south-western Ethiopia: a study of risk factors for infection and carriage. Int J Dermatol 1997; 36: 661-666.
11. Bergson CL, Conceicao F. Tinea capitis: study of asymptomatic carriers and sick adolescents, adults and elderly who live with children with the disease. Rev Inst Med Trop Sao Paulo 2001; 43: 87-91.
12. Williams JV, Honig PJ, McGinley KJ, Leyden JJ. Semiquantitative study of tinea capitis and the asymptomatic carrier state in inner-city school children. Pediatrics 1995; 96: 265-267.
13. Clayton YM. Superficial fungal infections. In: Harper J, Oranje A, Prose N (eds). Textbook of Pediatric Dermatology, 1999: 447-460.
14. Sharma V, Silverberg N, Howard R, Tran CT, Laude TA, Frieden IJ. Do hair care practices affect the acquisition of tinea capitis? Arch Pediatr Adolese Med 2001; 155: 818-821.
15. Mackenzie DWR. 'Hairbrush diagnosis' in detection and eradication of non-fluorescent scalp ringworm. Br Med J 1963; ii 363-365.
16. Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. Br J Dermatol 2000; 143: 53-58.
17. Bonifazi E, Berloco A. Antimycotic treatment in children. Eur J Pediatr Dermatol 2000; 10: 33-37.
18. Greer DL. Successful treatment of tinea capitis with 2% ketoconazole shampoo. Int J Dermatol 2000; 39: 3021-304.
19. Jones TC. Overview of the use of terbinafine (Lamisil) in children. Br J Dermatol 1995; 132: 683-689.
20. Friedlander SF, Aly R, Krafchik B, et al. Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study. Pediatrics 2002; 109: 602-607.
21. Krafchik B, Pelletier J. An open study of tinea capitis in 50 children treated with a 2-week course of oral terbinafine. J Am Acad Dermatol 1999; 41: 60-63.
22. Bennett ML, Fleischer AB, Loveless JW, Feldman SR. Oral griseofulvin remains the treatment of choice for tinea capitis in children. Pediatr Dermatol 2000; 17: 304-309.
23. Bruckbauer HR, Holman H. Systemic antifurgal treatment of children with terbinafine. Dermatology 1997; 195: 134-136.
24. Koumantaki E, Kakourou T, Rallis E, Riga P, Georgalla. S. Doubled dose of oral terbinafine is required for Microsporum canis tinea capitis. Pediatr Dermatol 2001; 18: 339-342.
25. Pomeranz AJ, Sabnis SS. Tinea capitis: epidemiology, diagnosis and management strategies. Paediatr Drugs 2002; 4 12): 779-83.